Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy - Wikidata - awgldk - TriplyDB

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

http://www.wikidata.org/entity/Q33728156

about

Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

P2860

Q47220295-FDB2AA2A-EBFE-4BE1-AFE7-E08BDFDF5C93

P2860

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

http://www.wikidata.org/entity/Q33728156

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

@ast

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

@en

type

label

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

@ast

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

@en

prefLabel

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

@ast

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

@en

P1433

Q33728156-8401833F-779F-4C8A-A6BD-D6EFB5219999

P1476

Q33728156-D6A2626F-4399-4910-8B86-8C4B153B3DC9

P2093

Q33728156-1D589C3B-AD43-4D3A-8B87-F39F00AF1683

Q33728156-270E316D-130B-41BF-9D9D-5EEAF8CAFDB8

Q33728156-48D37E82-AAE7-45A2-838E-8C1BD1CA86C9

Q33728156-7A874ABE-BDEA-4AFF-922F-3FE394F2293C

Q33728156-86F6FB3F-A900-4D3B-B7BB-C6C8C87E1D0B

Q33728156-92EEE821-12EB-41AE-9C3A-C2CA4E67274C

Q33728156-C1417A12-D734-4715-8F3A-0A7FA8E2F416

Q33728156-E7EB8F8A-E584-475A-82A0-5AED5A4483E0

Q33728156-F6C2FDD4-2EB9-480B-B8F8-778D6ACEB2EE

P2860

Q33728156-00E64173-1E62-429D-B1F5-80DCB7BCAA9D

Q33728156-01328768-F23A-4A3B-8BD2-C99694634397

Q33728156-1470CB81-AC0B-4F8C-8E42-7304C6D4C0E5

Q33728156-165B6AC7-1032-482E-8C7F-01E502E8F3B5

Q33728156-1EB692B4-F939-4959-8961-2A37477DCA2C

Q33728156-20D75118-5D33-49A8-A465-8CD13C9A7D8D

Q33728156-23BABD19-DC12-4422-AD65-A41A151D399F

Q33728156-263FEC07-5A4C-42AF-88FA-1F0D9D80DDEF

Q33728156-2AE3D8D4-FC69-4FFB-899C-22CFC743AABF

Q33728156-38C3685B-D10E-4688-961F-E2C19CB476B7

P304

Q33728156-AD6E633E-2E86-4243-8DFE-DC759EA5CC3C

P31

Q33728156-10BFA98C-E712-4825-82AF-944281D5CA00

P356

Q33728156-7286859A-F54F-4EBC-8659-52D7A452AAE2

P407

Q33728156-D0EB7E03-5427-4BCF-AF16-84418BB96D3C

P433

Q33728156-6DAD82C0-FCA2-4531-AFAA-2E49C1AC748A

P478

Q33728156-60954A44-4D63-4220-A758-1355D6DAECC4

P577

Q33728156-6D04F6BC-AD91-40AF-86DE-A037E8F73E8B

P698

Q33728156-9EB8F164-DE27-45E0-99EF-14DC5AA578DE

P932

Q33728156-A45255B1-3A11-4979-AAE0-56EAF9C8F3BA

P356

ONCOTARGET.16159

P1433

P1476

Nanocrystals of a new camptothecin derivative WCN-21 enhance its solubility and efficacy

@en

P2093

Chuanrui Xu

http://www.w3.org/2001/XMLSchema#string

Chun Li

http://www.w3.org/2001/XMLSchema#string

Fei Chen

http://www.w3.org/2001/XMLSchema#string

Jia You

http://www.w3.org/2001/XMLSchema#string

Pengxuan Zhao

http://www.w3.org/2001/XMLSchema#string

Xingyu Shen

http://www.w3.org/2001/XMLSchema#string

Yingqian Liu

http://www.w3.org/2001/XMLSchema#string

Yuyuan Chen

http://www.w3.org/2001/XMLSchema#string

Zubaeda M Mohamed Alsayeh

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity

Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo.

A nanoparticle size series for in vivo fluorescence imaging.

Review camptothecin: current perspectives.

Delivering nanomedicine to solid tumors.

Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration.

Nanosuspensions: a promising drug delivery strategy.

PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.

Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release

Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375

P304

29808-29822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16159

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28423733

http://www.w3.org/2001/XMLSchema#string

P932

5444705

http://www.w3.org/2001/XMLSchema#string